It is accepted that patients who possess the APOE4 allele, which plays role in amyloid beta aggregation and clearance, have an increased risk for developing AD (Durmaz et al., 2019; Pontifex et al., 2021). The gene discussed is APOE; the disease is Alzheimer disease.